WH Smith ticks up as it enters close period
0 mins. to read
Newsagent WH Smith said that results for the year ending 31st August will be in line with expectations as the company enters its close period.
Master Investor
Hunting scores big gains in the first half
0 mins. to read
International energy services provider Hunting earned revenues of $442.8 million during the six months ended 30th June, a 39.2% improvement over last year.
Build-up puts pressure on Solo Oil share price
0 mins. to read
Shares in AIM-listed Solo Oil fell by 4.15% to 2,16p (as of 14:30 BST) after it revealed that the pressure build-up at Kiliwani North has continued to grow.
James Fisher shares climb after positive first half
1 mins. to read
FTSE 250 marine services provider James Fisher and Sons has announced that revenues for the six months ended 30th June were £260.5 million.
Diploma rises on solid news and acquisition pipeline
0 mins. to read
Technical products and services supplier Diploma has announced that trading has been strong so far in the second half of its financial year.
MTI Wireless Edge shares and profits fall
1 mins. to read
AIM Antenna manufacturer MTI Wireless Edge said first-half revenues rose 3% to $17.1 million but operating profits for the period fell by 15.87%.
Sylvania Platinum shares shine on maiden dividend
0 mins. to read
AIM-listed mining outfit Sylvania Platinum has announced its maiden cash dividend of 0.35p after increasing net revenues by 24% to $62.8 million.
Bunzl buys Norwegian outfit and boosts revenues
0 mins. to read
International distribution specialist Bunzl saw its revenues grow by 12% to £4.34 billion during the six months ended 30th June.
Pantheon Resources shares rise after technical appointment
1 mins. to read
Shares in oil and gas outfit Pantheon Resources climbed after it appointed Professor Eric van Oort as a technical consultant.
Shire boosted by new US drug approval
0 mins. to read
Pharmaceuticals manufacturer Shire saw its shares rise by 2.16% to 4,518p after its Takhzyro treatment received approval from the United States FDA.